The present study aims to investigate PD-1 ligands’ upregulation and STAT3 activation as secondary immune resistance mechanisms elicited by AML and MDS cells upon exposure to IFN-γ under the maturation pressure by ATRA or D3 treatment. This evidence concerns the gene PDCD1 and acute myeloid leukemia.